Results 11 to 20 of about 1,279,582 (314)

Systemic sclerosis sine scleroderma. [PDF]

open access: yesAdvances in Clinical and Experimental Medicine, 2017
Systemic sclerosis is a rare generalized disease with scleroderma, i.e. skin thickening as one of the most common symptoms. The disease has 2 main subsets, diffuse and limited forms.
E. Kucharz, M. Kopeć-Mędrek
semanticscholar   +3 more sources

Frequency of disease-associated and other nuclear autoantibodies in patients of the German network for systemic scleroderma: correlation with characteristic clinical features [PDF]

open access: goldArthritis Research & Therapy, 2011
IntroductionIn the present study, we analysed in detail nuclear autoantibodies and their associations in systemic sclerosis (SSc) patients included in the German Network for Systemic Scleroderma Registry.MethodsSera of 863 patients were analysed ...
Rudolf Mierau   +24 more
openalex   +2 more sources

Systemic scleroderma. [PDF]

open access: yesThe Medical clinics of North America, 2020
Jennyy Sun   +3 more
semanticscholar   +3 more sources

Phosphodiesterase-4 inhibition in localized scleroderma: A case series of topical roflumilast [PDF]

open access: yesSAGE Open Medical Case Reports
Localized scleroderma, or morphea, is a chronic fibrosing skin condition with limited therapeutic options, particularly for patients who are elderly, immunocompromized, or intolerant to systemic immunosuppressants.
Ghassan Barnawi   +4 more
doaj   +2 more sources

Proteomic aptamer analysis reveals serum markers that characterize preclinical systemic sclerosis (SSc) patients at risk for progression toward definite SSc

open access: yesArthritis Research & Therapy, 2023
Background The study of molecular mechanisms characterizing disease progression may be relevant to get insights into systemic sclerosis (SSc) pathogenesis and to intercept patients at very early stage.
Chiara Bellocchi   +6 more
doaj   +1 more source

Pathophysiology of systemic sclerosis (scleroderma)

open access: yesKaohsiung Journal of Medical Sciences, 2022
Systemic sclerosis (scleroderma) is an autoimmune‐triggered chronic fibrosing disease that affects the skin and many other organs. Its pathophysiology is complex and involves an early endothelial damage, an inflammatory infiltrate and a resulting ...
A. Rosendahl, K. Schönborn, T. Krieg
semanticscholar   +1 more source

Renal Disease and Systemic Sclerosis: an Update on Scleroderma Renal Crisis

open access: yesClinical reviews in allergy and immunology, 2022
Scleroderma renal crisis (SRC) is a life-threatening complication of systemic sclerosis (SSc) with a mortality of 20% at 6 months. Once the leading cause of mortality in scleroderma (SSc), it remains a serious complication, often necessitating level ...
Alice Cole, V. Ong, C. Denton
semanticscholar   +1 more source

Fibrosing arthropathy in juvenile scleroderma

open access: yesСовременная ревматология, 2021
The group of scleroderma diseases includes a number of clinical entities, the main symptom of which is skin tightening. Scleroderma is a prominent example of these diseases, characterized by excessive synthesis and deposition of collagen in organs and ...
D. A. Dibrov   +2 more
doaj   +1 more source

A Role of Myocardin Related Transcription Factor-A (MRTF-A) in Scleroderma Related Fibrosis. [PDF]

open access: yes, 2015
In scleroderma (systemic sclerosis, SSc), persistent activation of myofibroblast leads to severe skin and organ fibrosis resistant to therapy. Increased mechanical stiffness in the involved fibrotic tissues is a hallmark clinical feature and a cause of ...
Abraham, D   +11 more
core   +12 more sources

Home - About - Disclaimer - Privacy